LEADER 01518cam  22003371a 4500001    cis19011171
005    20141211231501.0
007    he bmb020baca
008    970422s1903    dcu     b    f000 0 eng d
035    (Sirsi) J2124655
035     |z(Sirsi) J2124655
040    Congressional Information Service |cCongressional Information Service |dUtOrBLW
043    n-us-dc
049    EREE
086 0  T 27.14:V 81/1
099    CIS US Exec MF T2714-2
245 00 Regulations for sale of viruses, serums, toxins, and analogous products in D.C., etc.
260    Washington : |bU.S. G.P.O., |c1903.
300    8 pages ; |ccm.
336    text |2rdacontent
337    microform |2rdamedia
338    microfiche |2rdacarrier
500    Reuse of record except for individual research requires license from LexisNexis Academic & Library Solutions.
510 3  CIS Index to U.S. Executive Branch Documents, 1789-1909, Part 1.
533     |3Joyner-Microfiche. |b[Bethesda, Md.] : |cLexisNexis Academic & Library Solutions, |d1991. |e11 x 15 cm. |f(CIS US Executive Branch Documents, 1789-1909 : no. T2714-2).
650  0 Biological products |zWashington (D.C.) |=^A132664
650  0 Biologicals |xLaw and legislation |zWashington (D.C.) |=^A909766
710 1  United States. |bPublic Health and Marine Hospital Service. |=^A209334
596    1
998    1278246